Researchers in the Hadad Research Group, based in the Department of Chemistry and Biochemistry, Ohio State University, are studying organophosphate pesticides in vitro, and are using INTEGRA’s ASSIST PLUS pipetting robot to streamline workflows.
Point-of-care (POC) testing with screen-printed electrodes (SPEs) allows rapid testing of populations for viral outbreaks at affordable costs, without the need for trained specialists and/or complicated equipment.
Ultivue has announced a collaborative partnership with OracleBio to help further insights and advance personalised tumour characterisation in translational and clinical oncology research using multiplex immunofluorescence staining and imaging.
HORIBA UK, Medical has launched an affordable digital tool for online skill evaluation and training in cytology. The Quality Slide Program (QSP) 2.0 draws on the wealth of haematology expertise held within HORIBA Medical globally.
Freeline, a clinical stage adeno-associated virus (AAV)-based gene therapy company, has announced new data on its AAV gene therapy product candidate, FLT180a, in severe haemophilia B patients.
Horizon Discovery Group, a leader in gene editing and gene modulation for cell line engineering, has introduced its stably expressing Cas9 and dCas9-VPR cell lines to help accelerate gene knockout and gene activation experiments, respectively.
Doris-Ann Williams, Chief Executive of the British In Vitro Diagnostics Association (BIVDA), has commented on the economic announcements in the Chancellor of the Exchequer’s Summer Economic Update.
Public Health England (PHE) is asking for expressions of interest from suppliers that provide diagnostics, research and development, manufacturing of supplies and services, and provision of testing capacity for a new national microbiology framework.
INTEGRA Biosciences is offering the chance to win a VACUSAFE Aspiration System. A compact, all-in-one laboratory vacuum pump, it enables safe and efficient collection and containment of biological waste, meeting stringent biosafety level guidelines.
The University of Glasgow, with the NHS and Scottish technology companies, will lead a project to transform bowel screening by developing a diagnostic tool that uses artificial intelligence to predict who will develop future polyps and tumours.
Roche Diagnostics UK & Ireland is part of a consortium to win funding provided through UK Research and Innovation’s Industrial Strategy Challenge Fund to take forward projects to improve early diagnosis of cancer, thoracic and liver diseases.
SYNLAB VPG and Scopio Labs have collaborated to present a free online CPD webinar on in-house veterinary cytology hosted by VPG’s Laboratory Director and Veterinary Clinical Pathologist, Fiona Gosling.